Hydroxycitric acid compounds and capsule liquid delivery
AssigneeGlykon Technologies Group, LLC
InventorsDallas L. CLOUATRE, Daniel E. CLOUATRE
Life of this patent
Estimating the term…
Abstract
A capsule oral delivery system is disclosed. The system includes an outer capsule completely enclosing an inner content, or a hard shell comprised of hydroxypropyl methylcellulose (HPMC) enclosing the content. A liquid formulation forming the inner content of the outer capsule is comprised of a hydroxycitric acid (HCA) salt, water, and glycerol, with the HCA being completely dissolved in the water and glycerol which may be the only components present in the capsule, which may be administered to a patient in a method of treatment to cause weight loss when repeatedly administered.
Claims13
1-19. (canceled)
A method of treatment, comprising:
- administering to a subject a liquid formulation, comprising:
- a salt of hydroxycitric acid (HCA), water, and glycerol, whereby the HCA salt is completely dissolved in the water and glycerol;
- wherein the liquid formulation is prepared by mixing glycerol in water wherein the glycerol is present in an amount of about 1 to 3 parts by volume and the water is present in an amount of about 3 to 1 parts by volume to create a solution;
- dissolving hydroxycitrate salt in the solution wherein the hydroxycitrate salt is present in a concentration ranging from about 1.1 to 1.7 molar dosage;
- and
- repeating the administering over a period of time.
A method of treatment, comprising:
- administering to a subject a capsule with an outer capsule comprised of hydroxypropyl methylcellulose completely enclosing an inner content;
- wherein the inner content is liquid formulation comprising a potassium-magnesium salt of hydroxycitric acid (HCA), water, and glycerol, whereby the HCA salt is completely dissolved in the water and glycerol;
- wherein the liquid formulation is prepared by mixing glycerol in water wherein the glycerol is present in an amount of about 1 to 3 parts by volume and the water is present in an amount of about 3 to 1 parts by volume to create a solution;
- dissolving hydroxycitrate salt in the solution wherein the hydroxycitrate salt is present in a concentration ranging from about 1.1 to 1.7 molar dosage;
- and
- repeating the administering over a period of time.
Dependencies are inferred from the claim text.